Showing results (961-970 of 1,104) with videos related to
Sort By:
Pageof 111
Cancer Research|November 5, 2015
Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate CancerYu-Chen Lee, Song-Chang Lin, Guoyu Yu, et al.Nature Communications|April 17, 2025
Cryo-EM structures of the small-conductance Ca<sup>2+</sup>-activated K<sub>Ca</sub>2.2 channelYoung-Woo Nam, Dohyun Im, Ana Santa Cruz Garcia, et al.Molecular Cancer Research : MCR|January 23, 2013
Targeting constitutively activated β1 integrins inhibits prostate cancer metastasisYu-Chen Lee, Jung-Kang Jin, Chien-Jui Cheng, et al.European Urology Oncology|July 12, 2025
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node MetastasisAmado J Zurita, Rebecca S Tidwell, Brian F Chapin, et al.The Lancet. Oncology|September 14, 2019
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trialPaul G Corn, Elisabeth I Heath, Amado Zurita, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2024
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III TrialKarim Fizazi, Gwénaël Le Teuff, Aude Fléchon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate CancerPaymaneh D Malihi, Ryon P Graf, Angel Rodriguez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancerChristos N Papandreou, Danai D Daliani, Darrell Nix, et al.Neoplasia (New York, N.Y.)|January 26, 2016
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate CancerYuanyuan Qiao, Felix Y Feng, Yugang Wang, et al.Elife|May 25, 2018
Structure-based analysis of CysZ-mediated cellular uptake of sulfateZahra Assur Sanghai, Qun Liu, Oliver B Clarke, et al.Pageof 111